CPD-Accredited Webinar | DM1 Clinical and Translational Research Updates
NMD4C and MDC Canada are pleased to invite you to a CPD-accredited webinar on DM1 Clinical and Translational Research Updates. This webinar is primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular diseases. NMD4C and MDC are providing organizational and technical support. This is an independent clinical/academic webinar with no industry sponsorship or influence.
Speakers:
- Dr. Hanns Lochmüller: Updates on clinical trials in DM1
- Drs. Pauline Garcia & Nicolas Dumont: Muscle stem cell dysfunction in DM1: mechanisms and therapeutic perspectives
Details:
- Date: Tuesday, October 6, 2026
- Time: 5-6 pm ET
Learning Objectives:
- Define the molecular mechanisms underlying muscle stem cell defect in DM1
- Explore novel therapeutic approaches to improve muscle regeneration in DM1
- Understand current Canadian clinical trial opportunities for individuals with DM1
- Examine early safety and efficacy findings from oligonucleotide-based therapies for individuals with DM1.
The NMD Rounds & Educational Webinars are self-approved group learning activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
If you have any questions, please contact our Network Manger, Erin Beattie


